p stat3 rabbit polyclonal cell signaling technology Search Results


93
Bioss stat3 (6g5) monoclonal antibody
Stat3 (6g5) Monoclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3 (6g5) monoclonal antibody/product/Bioss
Average 93 stars, based on 1 article reviews
stat3 (6g5) monoclonal antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology stat3
Stat3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
stat3 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse monoclonal antibody
Mouse Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibody/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
mouse monoclonal antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Bioss stat3 (tyr705) polyclonal antibody
Stat3 (Tyr705) Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3 (tyr705) polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
stat3 (tyr705) polyclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti p stat3 y705
Figure 2. The expression patterns of EGFR and <t>IL-6-STAT3</t> in ovarian cancer. (A) Analysis of of IL-6 expression in ovarian cancer samples from TCGA database at http://gepia.cancer-pku.cn/. (B) Analysis of STAT3 expression in ovarian cancer tissues from the https://www.oncomine.org database. (C, D) The mRNA and protein lev- els of EGFR in ovarian cancer cell lines as determined by qPCR and Western blotting. (E) Analyses of mRNA levels of IL-6 in ovarian cancer samples (n ¼ 24) and control samples (n ¼ 24). (F) The relative mRNA levels of IL-6 in ovarian cancer cell lines. (G) The protein level of IL-6 as determined by Western blotting in ovarian cancer cell lines. (H) The concentration of IL-6 in cell supernatants cell supernatants as determined by flow cytometry in ovarian cancer cell lines. (I) The relative mRNA levels of STAT3 in ovarian cancer cell lines. (J) The relative expression of p-STAT3 <t>(Y705,</t> S727) and STAT3 in ovarian cancer cell lines was examined by Western blotting, and GAPDH was used as the internal control. The data are expressed as the means ± SDs; ns: not significant; p < 0.05; p < 0.01; p < 0.001.
Anti P Stat3 Y705, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p stat3 y705/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
anti p stat3 y705 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc stat3
Figure 2. The expression patterns of EGFR and <t>IL-6-STAT3</t> in ovarian cancer. (A) Analysis of of IL-6 expression in ovarian cancer samples from TCGA database at http://gepia.cancer-pku.cn/. (B) Analysis of STAT3 expression in ovarian cancer tissues from the https://www.oncomine.org database. (C, D) The mRNA and protein lev- els of EGFR in ovarian cancer cell lines as determined by qPCR and Western blotting. (E) Analyses of mRNA levels of IL-6 in ovarian cancer samples (n ¼ 24) and control samples (n ¼ 24). (F) The relative mRNA levels of IL-6 in ovarian cancer cell lines. (G) The protein level of IL-6 as determined by Western blotting in ovarian cancer cell lines. (H) The concentration of IL-6 in cell supernatants cell supernatants as determined by flow cytometry in ovarian cancer cell lines. (I) The relative mRNA levels of STAT3 in ovarian cancer cell lines. (J) The relative expression of p-STAT3 <t>(Y705,</t> S727) and STAT3 in ovarian cancer cell lines was examined by Western blotting, and GAPDH was used as the internal control. The data are expressed as the means ± SDs; ns: not significant; p < 0.05; p < 0.01; p < 0.001.
Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
stat3 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

stat3  (Bioss)
94
Bioss stat3
Figure 2. The expression patterns of EGFR and <t>IL-6-STAT3</t> in ovarian cancer. (A) Analysis of of IL-6 expression in ovarian cancer samples from TCGA database at http://gepia.cancer-pku.cn/. (B) Analysis of STAT3 expression in ovarian cancer tissues from the https://www.oncomine.org database. (C, D) The mRNA and protein lev- els of EGFR in ovarian cancer cell lines as determined by qPCR and Western blotting. (E) Analyses of mRNA levels of IL-6 in ovarian cancer samples (n ¼ 24) and control samples (n ¼ 24). (F) The relative mRNA levels of IL-6 in ovarian cancer cell lines. (G) The protein level of IL-6 as determined by Western blotting in ovarian cancer cell lines. (H) The concentration of IL-6 in cell supernatants cell supernatants as determined by flow cytometry in ovarian cancer cell lines. (I) The relative mRNA levels of STAT3 in ovarian cancer cell lines. (J) The relative expression of p-STAT3 <t>(Y705,</t> S727) and STAT3 in ovarian cancer cell lines was examined by Western blotting, and GAPDH was used as the internal control. The data are expressed as the means ± SDs; ns: not significant; p < 0.05; p < 0.01; p < 0.001.
Stat3, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3/product/Bioss
Average 94 stars, based on 1 article reviews
stat3 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc phospho stat3 ser727 cat
Fig. 4. SNG downregulates constitutively activated <t>JAK/STAT3</t> signaling pathway and IL6 mediated STAT3 activation in NCI-H-1975 and HCC-827 cellS (A). After 24 h of SNG treatment, NCI-H-1975 and HCC-827 cells were lysed, and western blotting was performed for antibodies against p-Jak2, Jak2, GAPDH, p-Src, Src, p- STAT3 (Try705 and <t>ser727),</t> and STAT3. (B) siRNA knockdown of STAT3. NCI-H-1975 were transfected with control (100 pM) and STAT3 siRNA (50 and 100 pM). Cells were lysed and separated, transferred on the PVDF membrane, and immunoblotted with antibodies against STAT3, Bcl-xL, caspase-3, cleaved caspase-3 and HSP60. (C) SNG inhibits IL 6 secretion in NCI-H-1975 and HCC-827 cells. The cells mentioned above were exposed to SNG for 24 h, as indicated. Using supernatant from the treated and untreated group, levels of IL 6 were determined using multiplex biometric ELISA-based immunoassay. (D) SNG inhibits IL6-induced STAT3 activation. NCI-H-1975 and HCC-827 cells were pretreated with 2.0 μM SNG for 1 h and then stimulated with IL6 (100 µg/ml). At the end of the treatment, cells were lysed and immunoblotted against p-STAT3 (Try705) and STAT3(ser727).
Phospho Stat3 Ser727 Cat, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho stat3 ser727 cat/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
phospho stat3 ser727 cat - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc activator
Fig. 4. SNG downregulates constitutively activated <t>JAK/STAT3</t> signaling pathway and IL6 mediated STAT3 activation in NCI-H-1975 and HCC-827 cellS (A). After 24 h of SNG treatment, NCI-H-1975 and HCC-827 cells were lysed, and western blotting was performed for antibodies against p-Jak2, Jak2, GAPDH, p-Src, Src, p- STAT3 (Try705 and <t>ser727),</t> and STAT3. (B) siRNA knockdown of STAT3. NCI-H-1975 were transfected with control (100 pM) and STAT3 siRNA (50 and 100 pM). Cells were lysed and separated, transferred on the PVDF membrane, and immunoblotted with antibodies against STAT3, Bcl-xL, caspase-3, cleaved caspase-3 and HSP60. (C) SNG inhibits IL 6 secretion in NCI-H-1975 and HCC-827 cells. The cells mentioned above were exposed to SNG for 24 h, as indicated. Using supernatant from the treated and untreated group, levels of IL 6 were determined using multiplex biometric ELISA-based immunoassay. (D) SNG inhibits IL6-induced STAT3 activation. NCI-H-1975 and HCC-827 cells were pretreated with 2.0 μM SNG for 1 h and then stimulated with IL6 (100 µg/ml). At the end of the treatment, cells were lysed and immunoblotted against p-STAT3 (Try705) and STAT3(ser727).
Activator, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/activator/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
activator - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc phospho stat3 tyr705
Fig. 3 Daily systemic injection of PTH activated <t>STAT3</t> in the alveolar bone, which could be reversed by local stattic injection. Representative images of immunohistochemical staining of STAT3 (a) and p-STAT3 <t>(Tyr705)</t> (b) in the OTM + PD, OTM + PD + PTH and OTM + PD + PTH + S groups, and relative quantitative analysis at days 7 and 14. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 by one-way ANOVA with Tukey’s post hoc test
Phospho Stat3 Tyr705, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho stat3 tyr705/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
phospho stat3 tyr705 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


Figure 2. The expression patterns of EGFR and IL-6-STAT3 in ovarian cancer. (A) Analysis of of IL-6 expression in ovarian cancer samples from TCGA database at http://gepia.cancer-pku.cn/. (B) Analysis of STAT3 expression in ovarian cancer tissues from the https://www.oncomine.org database. (C, D) The mRNA and protein lev- els of EGFR in ovarian cancer cell lines as determined by qPCR and Western blotting. (E) Analyses of mRNA levels of IL-6 in ovarian cancer samples (n ¼ 24) and control samples (n ¼ 24). (F) The relative mRNA levels of IL-6 in ovarian cancer cell lines. (G) The protein level of IL-6 as determined by Western blotting in ovarian cancer cell lines. (H) The concentration of IL-6 in cell supernatants cell supernatants as determined by flow cytometry in ovarian cancer cell lines. (I) The relative mRNA levels of STAT3 in ovarian cancer cell lines. (J) The relative expression of p-STAT3 (Y705, S727) and STAT3 in ovarian cancer cell lines was examined by Western blotting, and GAPDH was used as the internal control. The data are expressed as the means ± SDs; ns: not significant; p < 0.05; p < 0.01; p < 0.001.

Journal: Journal of enzyme inhibition and medicinal chemistry

Article Title: Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer.

doi: 10.1080/14756366.2021.1963240

Figure Lengend Snippet: Figure 2. The expression patterns of EGFR and IL-6-STAT3 in ovarian cancer. (A) Analysis of of IL-6 expression in ovarian cancer samples from TCGA database at http://gepia.cancer-pku.cn/. (B) Analysis of STAT3 expression in ovarian cancer tissues from the https://www.oncomine.org database. (C, D) The mRNA and protein lev- els of EGFR in ovarian cancer cell lines as determined by qPCR and Western blotting. (E) Analyses of mRNA levels of IL-6 in ovarian cancer samples (n ¼ 24) and control samples (n ¼ 24). (F) The relative mRNA levels of IL-6 in ovarian cancer cell lines. (G) The protein level of IL-6 as determined by Western blotting in ovarian cancer cell lines. (H) The concentration of IL-6 in cell supernatants cell supernatants as determined by flow cytometry in ovarian cancer cell lines. (I) The relative mRNA levels of STAT3 in ovarian cancer cell lines. (J) The relative expression of p-STAT3 (Y705, S727) and STAT3 in ovarian cancer cell lines was examined by Western blotting, and GAPDH was used as the internal control. The data are expressed as the means ± SDs; ns: not significant; p < 0.05; p < 0.01; p < 0.001.

Article Snippet: The antibodies used for Western blotting were as follows: anti-GAPDH (#60004–1-Ig, Proteintech, Wuhan, China), anti-IL-6 (#66146-Ig, Proteintech, Wuhan, China), anti-STAT3 (#4904 CST, Danvers, MA, USA), anti-P-STAT3 (Y705) (#9145, CST, Danvers, MA, USA), anti-P-STAT3 (S727) (#49081, CST, Danvers, MA, USA), anti-EGFR (#4267, CST, Danvers, MA, USA), anti-Flag (F1804, Sigma, USA), HRP-conjugated anti-mouse IgG (#70-GAM007, MultiSciences, China), and horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (#70-GAR007, MultiSciences, China).

Techniques: Expressing, Western Blot, Control, Concentration Assay, Flow Cytometry

Fig. 4. SNG downregulates constitutively activated JAK/STAT3 signaling pathway and IL6 mediated STAT3 activation in NCI-H-1975 and HCC-827 cellS (A). After 24 h of SNG treatment, NCI-H-1975 and HCC-827 cells were lysed, and western blotting was performed for antibodies against p-Jak2, Jak2, GAPDH, p-Src, Src, p- STAT3 (Try705 and ser727), and STAT3. (B) siRNA knockdown of STAT3. NCI-H-1975 were transfected with control (100 pM) and STAT3 siRNA (50 and 100 pM). Cells were lysed and separated, transferred on the PVDF membrane, and immunoblotted with antibodies against STAT3, Bcl-xL, caspase-3, cleaved caspase-3 and HSP60. (C) SNG inhibits IL 6 secretion in NCI-H-1975 and HCC-827 cells. The cells mentioned above were exposed to SNG for 24 h, as indicated. Using supernatant from the treated and untreated group, levels of IL 6 were determined using multiplex biometric ELISA-based immunoassay. (D) SNG inhibits IL6-induced STAT3 activation. NCI-H-1975 and HCC-827 cells were pretreated with 2.0 μM SNG for 1 h and then stimulated with IL6 (100 µg/ml). At the end of the treatment, cells were lysed and immunoblotted against p-STAT3 (Try705) and STAT3(ser727).

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway.

doi: 10.1016/j.biopha.2021.112358

Figure Lengend Snippet: Fig. 4. SNG downregulates constitutively activated JAK/STAT3 signaling pathway and IL6 mediated STAT3 activation in NCI-H-1975 and HCC-827 cellS (A). After 24 h of SNG treatment, NCI-H-1975 and HCC-827 cells were lysed, and western blotting was performed for antibodies against p-Jak2, Jak2, GAPDH, p-Src, Src, p- STAT3 (Try705 and ser727), and STAT3. (B) siRNA knockdown of STAT3. NCI-H-1975 were transfected with control (100 pM) and STAT3 siRNA (50 and 100 pM). Cells were lysed and separated, transferred on the PVDF membrane, and immunoblotted with antibodies against STAT3, Bcl-xL, caspase-3, cleaved caspase-3 and HSP60. (C) SNG inhibits IL 6 secretion in NCI-H-1975 and HCC-827 cells. The cells mentioned above were exposed to SNG for 24 h, as indicated. Using supernatant from the treated and untreated group, levels of IL 6 were determined using multiplex biometric ELISA-based immunoassay. (D) SNG inhibits IL6-induced STAT3 activation. NCI-H-1975 and HCC-827 cells were pretreated with 2.0 μM SNG for 1 h and then stimulated with IL6 (100 µg/ml). At the end of the treatment, cells were lysed and immunoblotted against p-STAT3 (Try705) and STAT3(ser727).

Article Snippet: Antibodies against caspase-9 (Cat. No. 9508), Bcl2 (Cat. No. 15071), phospho-STAT3 Tyr705- Cat. No. 9145, phospho-STAT3 Ser727- Cat. No. 9134, STAT3 Cat. No.12640, cleaved caspase-3 Cat. No. 9661, caspase-3 Cat. No. 9662, Bax (Cat. No.5023), Cytochrome c (Cat. No.12963), Tubulin (Cat. No.2144), GAPDH (Cat. No.5174), PARP ( Cat. No.9542) CLEAVED CASPASE 8 (Cat. No.9496), phospho-jak2 (Cat. No.3776), JAK2(Cat. No.3230), PH2AX(Cat. No.9718), phsopho-Src Tyr416 (Cat. No. 6943) and Src (Cat. No. 2108) were purchased from Cell Signaling Technologies (Beverly, USA).

Techniques: Activation Assay, Western Blot, Knockdown, Transfection, Control, Membrane, Multiplex Assay, Enzyme-linked Immunosorbent Assay

Fig. 7. SNG inhibits NCI-H-1975 xenograft tumor growth in ICR-SCID mice. Subcutaneous tumor was grown in donor mouse and then transplanted into ICR-SCID female mice and divided into treated and control groups as dis cussed under Materials and Methods. At the end of the study, the mice were sacrificed, and (A) excised tumors in each group were weighed and analyzed using graph pad prism software. The graph displays the mean ± SD of four inde pendent experiments (* P < 0.05). (B) Excised tumors were photographed (C) lysates obtained from excised tumors were immunoblotted against p-STAT3, STAT3, and actin antibodies. (D) Densitometric analysis of p-STAT3/STAT3 expression in control and SNG treated tumors. The graph displays the mean ± SD of four in dependent experiments (* P < 0.05).

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway.

doi: 10.1016/j.biopha.2021.112358

Figure Lengend Snippet: Fig. 7. SNG inhibits NCI-H-1975 xenograft tumor growth in ICR-SCID mice. Subcutaneous tumor was grown in donor mouse and then transplanted into ICR-SCID female mice and divided into treated and control groups as dis cussed under Materials and Methods. At the end of the study, the mice were sacrificed, and (A) excised tumors in each group were weighed and analyzed using graph pad prism software. The graph displays the mean ± SD of four inde pendent experiments (* P < 0.05). (B) Excised tumors were photographed (C) lysates obtained from excised tumors were immunoblotted against p-STAT3, STAT3, and actin antibodies. (D) Densitometric analysis of p-STAT3/STAT3 expression in control and SNG treated tumors. The graph displays the mean ± SD of four in dependent experiments (* P < 0.05).

Article Snippet: Antibodies against caspase-9 (Cat. No. 9508), Bcl2 (Cat. No. 15071), phospho-STAT3 Tyr705- Cat. No. 9145, phospho-STAT3 Ser727- Cat. No. 9134, STAT3 Cat. No.12640, cleaved caspase-3 Cat. No. 9661, caspase-3 Cat. No. 9662, Bax (Cat. No.5023), Cytochrome c (Cat. No.12963), Tubulin (Cat. No.2144), GAPDH (Cat. No.5174), PARP ( Cat. No.9542) CLEAVED CASPASE 8 (Cat. No.9496), phospho-jak2 (Cat. No.3776), JAK2(Cat. No.3230), PH2AX(Cat. No.9718), phsopho-Src Tyr416 (Cat. No. 6943) and Src (Cat. No. 2108) were purchased from Cell Signaling Technologies (Beverly, USA).

Techniques: Control, Software, Expressing

Fig. 3 Daily systemic injection of PTH activated STAT3 in the alveolar bone, which could be reversed by local stattic injection. Representative images of immunohistochemical staining of STAT3 (a) and p-STAT3 (Tyr705) (b) in the OTM + PD, OTM + PD + PTH and OTM + PD + PTH + S groups, and relative quantitative analysis at days 7 and 14. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 by one-way ANOVA with Tukey’s post hoc test

Journal: International journal of oral science

Article Title: Parathyroid hormone increases alveolar bone homoeostasis during orthodontic tooth movement in rats with periodontitis via crosstalk between STAT3 and β-catenin.

doi: 10.1038/s41368-020-00104-2

Figure Lengend Snippet: Fig. 3 Daily systemic injection of PTH activated STAT3 in the alveolar bone, which could be reversed by local stattic injection. Representative images of immunohistochemical staining of STAT3 (a) and p-STAT3 (Tyr705) (b) in the OTM + PD, OTM + PD + PTH and OTM + PD + PTH + S groups, and relative quantitative analysis at days 7 and 14. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 by one-way ANOVA with Tukey’s post hoc test

Article Snippet: The membranes were blocked with 5% skim milk or 5% BSA and incubated with primary antibodies against β-actin (Huabio, China), STAT3 (Huabio, China), phospho-STAT3 (Tyr705) (Cell Signaling Technology, USA), RUNX2 (Huabio, China), OSX (Abcam, UK), ALP (Huabio, China), OPN (Huabio, China), β-catenin (Huabio, China), RANKL (Abcam, UK) and OPG (Huabio, China) at 4 °C overnight, and rabbit and mouse secondary antibodies (Signalway Antibody, USA).

Techniques: Injection, Immunohistochemical staining, Staining

Fig. 6 IPTH promoted osteogenesis in vitro, which could be reduced by stattic. a Alp, Ibsp, Opn, Sp7, Pth1r, Cbfa1, Col1a1 and Bglap expression in each group. b Protein levels of RANKL and OPG. c RANKL and OPG mRNA levels and the RANKL/OPG ratio. d Protein levels of representative osteoblastic markers and p-STAT3 (Tyr705) and STAT3. e Alizarin red S staining and ALP staining. f Quantitative analysis of Alizarin red S staining. g Quantitative analysis of ALP. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 by one-way ANOVA with Tukey’s post hoc test

Journal: International journal of oral science

Article Title: Parathyroid hormone increases alveolar bone homoeostasis during orthodontic tooth movement in rats with periodontitis via crosstalk between STAT3 and β-catenin.

doi: 10.1038/s41368-020-00104-2

Figure Lengend Snippet: Fig. 6 IPTH promoted osteogenesis in vitro, which could be reduced by stattic. a Alp, Ibsp, Opn, Sp7, Pth1r, Cbfa1, Col1a1 and Bglap expression in each group. b Protein levels of RANKL and OPG. c RANKL and OPG mRNA levels and the RANKL/OPG ratio. d Protein levels of representative osteoblastic markers and p-STAT3 (Tyr705) and STAT3. e Alizarin red S staining and ALP staining. f Quantitative analysis of Alizarin red S staining. g Quantitative analysis of ALP. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1 by one-way ANOVA with Tukey’s post hoc test

Article Snippet: The membranes were blocked with 5% skim milk or 5% BSA and incubated with primary antibodies against β-actin (Huabio, China), STAT3 (Huabio, China), phospho-STAT3 (Tyr705) (Cell Signaling Technology, USA), RUNX2 (Huabio, China), OSX (Abcam, UK), ALP (Huabio, China), OPN (Huabio, China), β-catenin (Huabio, China), RANKL (Abcam, UK) and OPG (Huabio, China) at 4 °C overnight, and rabbit and mouse secondary antibodies (Signalway Antibody, USA).

Techniques: In Vitro, Expressing, Staining

Fig. 7 IPTH activated Wnt/β-catenin signalling, while inhibition of STAT3 activation suppressed this effect. a Colocalization of β-catenin and STAT3 by immunofluorescence. b β-catenin levels in nuclear fractions (active form) and whole cells. c Axin2 expression level. d Ctnnb1 expression level. e Sost expression level. f A diagram showing the hypothesis that PTH regulates STAT3 and Wnt/β-catenin signalling. *P < 0.05, **P < 0.01 by one-way ANOVA with Tukey’s post hoc test

Journal: International journal of oral science

Article Title: Parathyroid hormone increases alveolar bone homoeostasis during orthodontic tooth movement in rats with periodontitis via crosstalk between STAT3 and β-catenin.

doi: 10.1038/s41368-020-00104-2

Figure Lengend Snippet: Fig. 7 IPTH activated Wnt/β-catenin signalling, while inhibition of STAT3 activation suppressed this effect. a Colocalization of β-catenin and STAT3 by immunofluorescence. b β-catenin levels in nuclear fractions (active form) and whole cells. c Axin2 expression level. d Ctnnb1 expression level. e Sost expression level. f A diagram showing the hypothesis that PTH regulates STAT3 and Wnt/β-catenin signalling. *P < 0.05, **P < 0.01 by one-way ANOVA with Tukey’s post hoc test

Article Snippet: The membranes were blocked with 5% skim milk or 5% BSA and incubated with primary antibodies against β-actin (Huabio, China), STAT3 (Huabio, China), phospho-STAT3 (Tyr705) (Cell Signaling Technology, USA), RUNX2 (Huabio, China), OSX (Abcam, UK), ALP (Huabio, China), OPN (Huabio, China), β-catenin (Huabio, China), RANKL (Abcam, UK) and OPG (Huabio, China) at 4 °C overnight, and rabbit and mouse secondary antibodies (Signalway Antibody, USA).

Techniques: Inhibition, Activation Assay, Expressing